Correlation Between Inozyme Pharma and MDxHealth

Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and MDxHealth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and MDxHealth into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inozyme Pharma and MDxHealth SA ADR, you can compare the effects of market volatilities on Inozyme Pharma and MDxHealth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of MDxHealth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and MDxHealth.

Diversification Opportunities for Inozyme Pharma and MDxHealth

0.66

Correlation Coefficient

Inozyme Pharma  MDxHealth

Poor diversification

The 3 months correlation between Inozyme and MDxHealth is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and MDxHealth SA ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MDxHealth SA ADR and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with MDxHealth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MDxHealth SA ADR has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and MDxHealth go up and down completely randomly.

Pair Corralation between Inozyme Pharma and MDxHealth

Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the MDxHealth. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.07 times less risky than MDxHealth. The stock trades about -0.27 of its potential returns per unit of risk. The MDxHealth SA ADR is currently generating about -0.14 of returns per unit of risk over similar time horizon. If you would invest  291.00  in MDxHealth SA ADR on August 31, 2024 and sell it today you would lose (95.00) from holding MDxHealth SA ADR or give up 32.65% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Inozyme Pharma  vs.  MDxHealth SA ADR

Inozyme Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

MDxHealth SA ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MDxHealth SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Inozyme Pharma and MDxHealth

The main advantage of trading using opposite Inozyme Pharma and MDxHealth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, MDxHealth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MDxHealth will offset losses from the drop in MDxHealth's long position.

The idea behind Inozyme Pharma and MDxHealth SA ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.